158 related articles for article (PubMed ID: 38392064)
41. Can ratio of the biggest tumor diameter to total tumor diameter be a new parameter in the differential diagnosis of agressive and favorable multifocal papillary thyroid microcarcinoma?
Tam AA; Özdemir D; Çuhacı N; Başer H; Dirikoç A; Aydın C; Yazgan AK; Ersoy R; Çakır B
Oral Oncol; 2017 Feb; 65():1-7. PubMed ID: 28109462
[TBL] [Abstract][Full Text] [Related]
42. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
43. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract][Full Text] [Related]
44. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
45. RISK FACTORS FOR CENTRAL LYMPH NODE METASTASES IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.
Wu X; Li B; Zheng C; He X
Endocr Pract; 2018 Dec; 24(12):1057-1062. PubMed ID: 30289307
[TBL] [Abstract][Full Text] [Related]
46. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
47. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
[No Abstract] [Full Text] [Related]
48. Thyrotropin (TSH) and thyroid autoimmunity are predictive factors for the incidental discovery of papillary thyroid microcarcinoma during thyroidectomy.
Kyrilli A; Schoinochoriti R; Chatzopoulos V; Bahar N; Bouziotis J; D'Haene N; Salmon I; Ruiz M; Corvilain B
Endocrine; 2024 Jun; ():. PubMed ID: 38896365
[TBL] [Abstract][Full Text] [Related]
49. Nodal metastasis and recurrence in papillary thyroid microcarcinoma.
Pisanu A; Saba A; Podda M; Reccia I; Uccheddu A
Endocrine; 2015 Mar; 48(2):575-81. PubMed ID: 25007850
[TBL] [Abstract][Full Text] [Related]
50. Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries.
Malandrino P; Pellegriti G; Attard M; Violi MA; Giordano C; Sciacca L; Regalbuto C; Squatrito S; Vigneri R
J Clin Endocrinol Metab; 2013 Apr; 98(4):1427-34. PubMed ID: 23482606
[TBL] [Abstract][Full Text] [Related]
51. [Non-incidental papillary microcarcinomas of the thyroid].
Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
[TBL] [Abstract][Full Text] [Related]
52. Detection of Tumor Multifocality Is Important for Prediction of Tumor Recurrence in Papillary Thyroid Microcarcinoma: A Retrospective Study and Meta-Analysis.
Pyo JS; Sohn JH; Kang G
J Pathol Transl Med; 2016 Jul; 50(4):278-86. PubMed ID: 27271109
[TBL] [Abstract][Full Text] [Related]
53. Thyroid surgical practices shaping thyroid cancer incidence in North-Eastern Italy.
Pelizzo MR; Rubello D; Bernardi C; Gemo G; Bertazza L; Schievano E; Fedeli U
Biomed Pharmacother; 2014 Feb; 68(1):39-43. PubMed ID: 24184200
[TBL] [Abstract][Full Text] [Related]
54. Papillary thyroid microcarcinomas: big decisions for a small tumor.
Haymart MR; Cayo M; Chen H
Ann Surg Oncol; 2009 Nov; 16(11):3132-9. PubMed ID: 19653044
[TBL] [Abstract][Full Text] [Related]
55. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
56. Long-term follow-up ultrasonography after lobectomy in papillary thyroid microcarcinoma patients: A single-center study.
Kim DW
Endocr Res; 2016 Aug; 41(3):213-7. PubMed ID: 26864682
[TBL] [Abstract][Full Text] [Related]
57. ANALYSIS OF POSTOPERATIVE ULTRASONOGRAPHY SURVEILLANCE AFTER HEMITHYROIDECTOMY IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA: A MULTICENTER STUDY.
Baek HJ; Kim DW; Lee CY; Huh JY; Sung JY; Choi YJ
Endocr Pract; 2017 Jul; 23(7):794-802. PubMed ID: 28448763
[TBL] [Abstract][Full Text] [Related]
58. Appropriate Neck Ultrasonography Surveillance During the First 10 Years After Hemithyroidectomy in Papillary Thyroid Microcarcinoma Patients: A Single-Center Study.
Choi YS; Kim DW; Lee YJ; Ha TK; Jung SJ; Baek HJ
Ultrasound Q; 2019 Sep; 35(3):275-280. PubMed ID: 30789488
[TBL] [Abstract][Full Text] [Related]
59. Incidental papillary microcarcinoma of the thyroid.
Ertorer ME; Tutuncu NB; Ozyilkan O
Asian Pac J Cancer Prev; 2007; 8(4):631-4. PubMed ID: 18260743
[TBL] [Abstract][Full Text] [Related]
60. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk.
Papini E; Guglielmi R; Gharib H; Misischi I; Graziano F; Chianelli M; Crescenzi A; Bianchini A; Valle D; Bizzarri G
Thyroid; 2011 Aug; 21(8):917-20. PubMed ID: 21595556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
